Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.86 EUR | 0.00% | +9.50% | +2.81% |
Apr. 23 | Reduced a short on DiaSorin, increased on STM. | AN |
Apr. 23 | Futures up; wait for Eurozone PMI | AN |
Sales 2024 * | 1.18B 1.26B | Sales 2025 * | 1.27B 1.36B | Capitalization | 5.12B 5.48B |
---|---|---|---|---|---|
Net income 2024 * | 185M 198M | Net income 2025 * | 214M 229M | EV / Sales 2024 * | 4.85 x |
Net Debt 2024 * | 607M 650M | Net Debt 2025 * | 423M 453M | EV / Sales 2025 * | 4.36 x |
P/E ratio 2024 * |
29.8
x | P/E ratio 2025 * |
25.1
x | Employees | 3,209 |
Yield 2024 * |
0.98% | Yield 2025 * |
1.09% | Free-Float | 37.71% |
Latest transcript on DiaSorin S.p.A.
1 week | +9.50% | ||
Current month | +7.11% | ||
1 month | +8.71% | ||
3 months | +13.58% | ||
6 months | +16.08% | ||
Current year | +2.81% |
Managers | Title | Age | Since |
---|---|---|---|
Carlo Rosa
CEO | Chief Executive Officer | 58 | 97-12-31 |
Director of Finance/CFO | 53 | 10-12-31 | |
Director/Board Member | 61 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 22-04-28 | |
Michele Denegri
CHM | Chairman | 55 | 07-03-25 |
Carlo Rosa
CEO | Chief Executive Officer | 58 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.76% | 16 M€ | -7.93% | ||
0.69% | 5 M€ | +12.55% | ||
0.17% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 95.86 | +0.97% | 279,687 |
24-04-22 | 94.94 | +4.12% | 266,838 |
24-04-19 | 91.18 | +1.79% | 161,180 |
24-04-18 | 89.58 | -1.08% | 187,114 |
24-04-17 | 90.56 | +3.66% | 376,490 |
Real-time Borsa Italiana, April 23, 2024 at 11:44 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.81% | 5.39B | |
+0.80% | 12.66B | |
-12.75% | 7.04B | |
-1.37% | 4.45B | |
+3.89% | 4.32B | |
-50.71% | 3.31B | |
+9.29% | 2.6B | |
-15.10% | 2.01B | |
-2.82% | 1.67B | |
-14.72% | 1.65B |
- Stock Market
- Equities
- DIA Stock